These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29075166)

  • 1. Retraction: Nonalcoholic fatty liver disease, diet and gut microbiota.
    Finelli C; Tarantino G
    EXCLI J; 2017; 16():1164. PubMed ID: 29075166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retraction.
    Saudi J Anaesth; 2020; 14(3):422. PubMed ID: 32934651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retraction note to four articles published in
    Cui Q
    World J Orthop; 2018 Mar; 9(3):58-59. PubMed ID: 29564215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis.
    Chiu CC; Ching YH; Li YP; Liu JY; Huang YT; Huang YW; Yang SS; Huang WC; Chuang HL
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29113135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retraction.
    Saudi J Anaesth; 2022; 16(1):144. PubMed ID: 35261616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retraction Note.
    Kowsar Publishing Company
    Iran Red Crescent Med J; 2016 Mar; 18(3):e43586. PubMed ID: 27830082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation.
    van Best N; Jansen PL; Rensen SS
    Hepatol Int; 2015 Jul; 9(3):406-15. PubMed ID: 26067771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferulic acid ameliorates nonalcoholic fatty liver disease and modulates the gut microbiota composition in high-fat diet fed ApoE
    Ma Y; Chen K; Lv L; Wu S; Guo Z
    Biomed Pharmacother; 2019 May; 113():108753. PubMed ID: 30856537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT3 Deficiency Promotes High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Correlation with Impaired Intestinal Permeability through Gut Microbial Dysbiosis.
    Chen M; Hui S; Lang H; Zhou M; Zhang Y; Kang C; Zeng X; Zhang Q; Yi L; Mi M
    Mol Nutr Food Res; 2019 Feb; 63(4):e1800612. PubMed ID: 30525304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota?
    Li DY; Yang M; Edwards S; Ye SQ
    JPEN J Parenter Enteral Nutr; 2013 Nov; 37(6):787-93. PubMed ID: 23538296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis.
    Ye JZ; Li YT; Wu WR; Shi D; Fang DQ; Yang LY; Bian XY; Wu JJ; Wang Q; Jiang XW; Peng CG; Ye WC; Xia PC; Li LJ
    World J Gastroenterol; 2018 Jun; 24(23):2468-2481. PubMed ID: 29930468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier.
    Li Y; Liu T; Yan C; Xie R; Guo Z; Wang S; Zhang Y; Li Z; Wang B; Cao H
    Mol Pharm; 2018 Sep; 15(9):3860-3870. PubMed ID: 30036479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retraction: The role of gut microbiome in the pathogenesis of psoriasis and the therapeutic effects of probiotics.
    J Family Med Prim Care; 2021 Feb; 10(2):1076. PubMed ID: 34041131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty Liver Disease and Gut Microbiota: A Comprehensive Update.
    Campo L; Eiseler S; Apfel T; Pyrsopoulos N
    J Clin Transl Hepatol; 2019 Mar; 7(1):56-60. PubMed ID: 30944821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.
    de Faria Ghetti F; Oliveira DG; de Oliveira JM; de Castro Ferreira LEVV; Cesar DE; Moreira APB
    Eur J Nutr; 2018 Apr; 57(3):861-876. PubMed ID: 28875318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic Fatty Liver Disease and the Gut Microbiome.
    Boursier J; Diehl AM
    Clin Liver Dis; 2016 May; 20(2):263-75. PubMed ID: 27063268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retraction.
    Muscles Ligaments Tendons J; 2015; 5(2):56. PubMed ID: 26261780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models.
    Ishioka M; Miura K; Minami S; Shimura Y; Ohnishi H
    Dig Dis Sci; 2017 Feb; 62(2):396-406. PubMed ID: 27913996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
    Suk KT; Kim DJ
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota of Nonalcoholic Fatty Liver Disease.
    Abdou RM; Zhu L; Baker RD; Baker SS
    Dig Dis Sci; 2016 May; 61(5):1268-81. PubMed ID: 26898658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.